Logo for Cyxone

Cyxone Investor Relations Material

Latest events

Logo for Cyxone

Q1 2024

14 May, 2024
Logo for Cyxone

Q4 2023

27 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Cyxone

Access all reports
Cyxone AB (publ) is a clinical biotech company focusing on the development of new therapies to treat autoimmune diseases and acute respiratory disorders. The company's lead products include Cyxonexim (rheumatoid arthritis), and Cyxonidexim (multiple sclerosis).